Guardant Health Investor Presentation

Significant opportunities to drive future growth. OMNI FDA approval Medicare NCD (pan-cancer) Commercial payer reimbursement Pharma CDx Medicare LCD (lung) tailwinds Near-term drivers Blood-First Volume Growth GUARDANT 360 OMNI LUNAR-2 LUNAR-1 Increased International expansion Continued COGS and adoption of CGP opex leverage 27 Long-term drivers GUARDANT

View entire presentation